Embarc

Leadership

Kishan (a/k/a Kishen) Mehta

SPACs
2
$200M
Biotech
DNAB
  1. Pre IPO
  2. Searching
  3. Definitive Agreement
  4. Completed
Unit Split
Social Capital Suvretta Holdings Corp. II
$200M
Biotech
DNAD
  1. Pre IPO
  2. Searching
  3. Definitive Agreement
  4. Completed
Unit Split
Social Capital Suvretta Holdings Corp. IV